HIGHLIGHTS
- who: Ni Yang from the Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, China have published the research work: Peptide-anchored neutrophil membrane-coated biomimetic nanodrug for targeted treatment of rheumatoid arthritis, in the Journal: (JOURNAL)
- what: The authors develop a biomimetic ApoA-I mimetic peptide-modified membrane-wrapped F127 polymer and chemokine receptors on neutrophils the membrane coating can endow the nanocarrier with synovitis-targeting ability with subsequent recruitment to the synovial fluid under the chemotactic effects of IL-8.
- how: All animal studies were conducted in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.